Peptide vaccine IPX

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Peptide vaccine IPX
Treatment and conditionWhere it standsTrials
Peptide vaccine IPX for rhabdomyosarcomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Peptide vaccine IPX for sarcoma, ewingPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Peptide vaccine IPX for sarcoma, synovialPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1